Mitre Medical

Mitre_Medical_LOGO_HI-REZ

Mitre Medical Corp. Strengthens Its Team with New Strategic Advisor Maria Sainz. CEO John MacMahon to Present April 19 at Dublin MedTech Innovators Competition

Silicon Valley, April 17, 2018 – Mitre Medical Corp. announces successful recruitment of experienced cardiac surgery business executive Maria Sainz as a Strategic Advisor. Ms. Sainz brings more than two decades of medical device industry experience most recently as President and CEO of CardioKinetix. Notable among prior senior leadership roles, she served as President of … Read more

Completion of the feasibility phase for the Mitral Touch® device clinical trial.

Silicon Valley, 03/28/2018 – Mitre Medical Corp. announces completion of the feasibility phase of the Study of the Mitral Touch System for the Reduction of Mitral Valve Regurgitation (the EnraptMR Trial).  Treatment with the Mitral Touch implant has demonstrated safety and technical success including durability of MR reduction at 30 days. “Validation of durable MR reduction on … Read more

Mitre Medical Corp. announces the initial clinical trial enrollment for beating heart surgical mitral regurgitation (MR) reduction with the Mitral Touch® device.

01/26/2018 –This less invasive procedure offers an alternative approach to mitigate moderate to severe mitral regurgitation. Silicon Valley, 01/26/2018 – Mitre Medical Corp. announces the initial enrollment of patients treated with the Mitral Touch epicardial annuloplasty device. The procedures were performed by cardiac surgeons Kestutis Rucinskas, MD, Ph.D. and Gintaras Kalinauskas, M.D. of Vilnius University … Read more

Press Release

Mitre Medical Corp. announces the initial clinical trial enrollment for beating heart surgical mitral regurgitation (MR) reduction with the Mitral Touch® device. This less invasive procedure offers an alternative approach to mitigate moderate to severe mitral regurgitation. Silicon Valley, 01/26/2018 – Mitre Medical Corp. announces the initial enrollment of patients treated with the Mitral Touch … Read more

Ex etur molestiorum ressuntota voluptur?

Lese dolorep rorepeliquam quam rerum conectur, vellam, officatiasi dem quo odi dolore non perisqui a cupta aut qui to dolupta se cone volestibus autent ime pos que latio. Ne dem amus et venditat repuditem. Ehente nobitatio qui deliquunt.

Ex etur molestiorum ressuntota voluptur?

Lese dolorep rorepeliquam quam rerum conectur, vellam, officatiasi dem quo odi dolore non perisqui a cupta aut qui to dolupta se cone volestibus autent ime pos que latio. Ne dem amus et venditat repuditem. Ehente nobitatio qui deliquunt.

Ex etur molestiorum ressuntota voluptur?

Lese dolorep rorepeliquam quam rerum conectur, vellam, officatiasi dem quo odi dolore non perisqui a cupta aut qui to dolupta se cone volestibus autent ime pos que latio. Ne dem amus et venditat repuditem. Ehente nobitatio qui deliquunt.